Trade

Indraprastha Medical Corporation share price

High risk
  • 45%Low risk
  • 45%Moderate risk
  • 45%Balanced risk
  • 45%High risk
  • 45%Extreme risk
  • 400.50(2.47%)
    February 10, 2026 15:29:16 PM IST
    • NSE
    • BSE
  • Vol : 280.07 K (NSE + BSE)
    Last 20 day avg : 268.05 K

Indraprastha Medical Corporation is trading 2.47% upper at Rs 400.50 as compared to its last closing price. Indraprastha Medical Corporation has been trading in the price range of 407.00 & 379.95. Indraprastha Medical Corporation has given -12.63% in this year & 4.19% in the last 5 days. Indraprastha Medical Corporation has TTM P/E ratio 22.46 as compared to the sector P/E of 26.16.There are 1 analysts who have initiated coverage on Indraprastha Medical Corporation. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 41.00 Crores in its last quarter.Listed peers of Indraprastha Medical Corporation include Narayana Hrudayalaya (2.76%), Fortis Healthcare (0.02%), Global Health (-2.15%).The Mutual Fund holding in Indraprastha Medical Corporation was at 2.62% in 30 Sep 2025. The MF holding has decreased from the last quarter. The FII holding in Indraprastha Medical Corporation was at 2.72% in 31 Dec 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Feb 10, 2026, 01:30 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.05
    Medium volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.05
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    1.19
    Higher than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    5.82
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    18.97
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.47
    Indicates undervaluation
Price range
Day Range
Lowest
379.95
Highest
407.00
52 week range
Lowest
307.90
Highest
640.05
Indraprastha Medical Corporation Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Narayana Hrudayalaya
Moderately Bearish
1,793.302.7636,644.8847.6610.510.2459.03
Fortis Healthcare
Bullish
891.500.0267,255.4780.047.640.1125.92
Global Health
Neutral
1,135.65-2.1530,456.9561.739.450.0418.41
Max Healthcare Institute
Neutral
1,021.151.1299,294.1393.4311.210.1429.50
Apollo Hospitals Enterprise
Neutral
7,220.000.121,03,812.5271.0912.560.2683.18
Mutual Fund Ownership
View all
Quant Small Cap Fund Growth
4/5
  • Amount Invested (Cr.) 105.70
  • % of AUM 0.37
Bandhan BSE Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.03
  • % of AUM 0.15
Indraprastha Medical Corporation Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-03Quarterly Results
2025-11-01Quarterly Results
2025-08-06Quarterly Results
2025-05-16Audited Results & Final Dividend
2025-02-03Quarterly Results
About the company Indraprastha Medical Corporation
  • IndustryHealthcare Facilities
  • ISININE681B01017
  • BSE Code532150
  • NSE CodeINDRAMEDCO
Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. It has approximately 52 specialties under one roof with the major specialties being anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics & gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, neurosciences, ophthalmology, orthopedics, otolaryngology (ENT), pediatrics, pediatric surgery, psychiatry and clinical psychology, rheumatology, spine surgery, urology and andrology and vascular and endovascular surgery.
  • Management Info
  • C. TyagiChief Financial Officer
  • Priya RanjanCompliance Officer, Company Secretary
  • P. ShivakumarManaging Director, Executive Director
Indraprastha Medical Corporation Share Price FAQs

Indraprastha Medical Corporation is trading at 400.50 as on Tue Feb 10 2026 09:59:16. This is 2.47% upper as compared to its previous closing price of 390.85.

The market capitalization of Indraprastha Medical Corporation is 3679.51 Cr as on Tue Feb 10 2026 09:59:16.

The average broker rating on Indraprastha Medical Corporation is Strong Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 0.00 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Indraprastha Medical Corporation is 640.05 whereas the 52 wk low is 307.90

Indraprastha Medical Corporation can be analyzed on the following key metrics -

  • TTM P/E: 22.46
  • Sector P/E: 26.16
  • Dividend Yield: 1.15%
  • D/E ratio: -

Indraprastha Medical Corporation reported a net profit of 160.99 Cr in 2025.

The Mutual Fund Shareholding was 2.62% at the end of 30 Sep 2025.